RoB 2: a revised tool for assessing risk of bias in randomised trials
By J. Sterne, J. Savović, Matthew J. Page, R. Elbers, N. Blencowe, I. Boutron, C. Cates, Hung-Yuan Cheng, M. Corbett, S. Eldridge and 18 more. British medical journal, 2019
28,662 citations recorded by the source corpus.
Assessment of risk of bias is regarded as an essential component of a systematic review on the effects of an intervention. The most commonly used tool for randomised trials is the Cochrane risk-of-bias tool. We updated the tool to respond to developments in understanding how bias arises in randomised trials, and to address user feedback on and limitations of the original tool.
Subfields: Economics and Econometrics, Sociology and Political Science, Statistics and Probability
View Paper: https://www.semanticscholar.org/paper/4e20cb972bbb43bc7bcabb2f2c9fdf980a9445d2
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Economics and Econometrics
In Sociology and Political Science
In Statistics and Probability
- Michael Noetel
- Luke A. McGuinness
- J. Yepes‐Nuñez
- G. Úrrutia
- Marta Romero-García
- S. Alonso-Fernández
- Julian P. T. Higgins
- Ian R. White
Citations in the corpus
- Co-infections in people with COVID-19: a systematic review and meta-analysis (2020, positive): “The Cochrane Risk of Bias Tool (version 2) was used to assess risk of bias in randomised controlled trials (RCTs).(17)”
- Risk‐of‐bias VISualization (robvis): An R package and Shiny web app for visualizing risk‐of‐bias assessments (2020, positive): “Within each bias domain a judgement is reached about the strength of the study in that regard: for example, the first domain in the Cochrane RoB 2 tool deals with bias arising from the randomization process.(3) Accessible graphics summarizing the results of these domain-based risk-of-bias assessment”
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. (2021, methodology): “For example, technological advances have enabled the use of natural language processing and machine learning to identify relevant evidence [22–24] , methods have been proposed to synthesise and present findings when meta-analysis is not possible or appropriate [25–27] , and new methods have been dev”
- Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials (2024, methodology): “70 Although assessments of bias between the two tools are generally comparable, 71 the RoB 1 tool can be more conservative when assessing open label studies with subjective assessments (eg, unblinded studies with self-reported measures for depression).”